A novel method for assessment of natural killer cell cytotoxicity using image cytometry

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Somanchi, Srinivas S ^a   McCulley, Kelsey J ^b   Somanchi, Anitha ^a,c   Chan, Leo L ^b   Lee, Dean A ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Nexcelom Bioscience LLC   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CALCEIN RELEASE ASSAY; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; FLUORESCENCE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE CYTOMETRY; MEASUREMENT ACCURACY; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; RELEASE ASSAY; SENSITIVITY AND SPECIFICITY; COMPARATIVE STUDY; CYTOTOXICITY TEST; FLOW CYTOMETRY; METABOLISM; NATURAL KILLER CELL; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE;

CALCEIN AM; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE;

APOPTOSIS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; FLUORESCEINS; FLUORESCENT DYES; HUMANS; IMAGE CYTOMETRY; KILLER CELLS, NATURAL; TUMOR CELLS, CULTURED;

EID: 84949460648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141074     Document Type: Article

References (46)

1. Lodoen MB, Lanier LL. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol. 2006; 18(4):391-8. doi: 10.1016/j.coi.2006.05.002
2. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001; 97(10):3146-51.
3. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol. 2001; 1(1):41-9. doi: 10.1038/35095564
4. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 2004; 294(1-2):15-22. doi: 10.1016/j.jim.2004.08.008
5. Vainio T, Koskimies O, Perlmann P, Perlmann H, Klein G. In Vitro Cytotoxic Effect of Lymphoid Cells from Mice Immunized with Allogeneic Tissue. Nature. 1964; 204:453-5.
6. Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology. 1968; 14(2):181-96. PMID: 4966657; PubMed Central PMCID: PMC1409286.
7. Fehniger TA, Bluman EM, Porter MM, Mrozek E, Cooper MA, VanDeusen JB, et al. Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. J Clin Invest. 2000; 106(1):117-24. doi: 10.1172/JCI6218 PMID: 10880055; PubMed Central PMCID: PMC314354.
8. Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res. 2012; 72(6):1407-15. doi: 10.1158/0008-5472.CAN-11-2544
9. Carbone E, Ruggiero G, Terrazzano G, Palomba C, Manzo C, Fontana S, et al. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J Exp Med. 1997; 185(12):2053-60. PMID: 9182676; PubMed Central PMCID: PMC2196353.
10. Binyamin L, Alpaugh RK, Hughes TL, Lutz CT, Campbell KS, Weiner LM. Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy. J Immunol. 2008; 180(9):6392-401. PMID: 18424763; PubMed Central PMCID: PMC2810560.
11. Kurago ZB, Lutz CT, Smith KD, Colonna M. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells. J Immunol. 1998; 160(4):1573-80.
12. Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R. CARE-LASS (calcein-release-Assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods. 1994; 172(2):227-39.
13. Kim GG, Donnenberg VS, Donnenberg AD, Gooding W, Whiteside TL. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay. J Immunol Methods. 2007; 325(1-2):51-66. PMID: 17617419; PubMed Central PMCID: PMC2040258.
14. Radosevic K, Garritsen HS, Van Graft M, De Grooth BG, Greve J. A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells. J Immunol Methods. 1990; 135(1-2):81-9.
15. Valiathan R, Lewis JE, Melillo AB, Leonard S, Ali KH, Asthana D. Evaluation of a flow cytometry-based assay for natural killer cell activity in clinical settings. Scand J Immunol. 2012; 75(4):455-62. doi: 10. 1111/j.1365-3083.2011.02667.x
16. Cho D, Shook DR, Shimasaki N, Chang YH, Fujisaki H, Campana D. Cytotoxicity of activated natural killer cells against pediatric solid tumors. Clin Cancer Res. 2010; 16(15):3901-9. doi: 10.1158/1078-0432.CCR-10-0735 PMID: 20542985; PubMed Central PMCID: PMC3168562.
17. Flieger D, Gruber R, Schlimok G, Reiter C, Pantel K, Riethmuller G. A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells. J Immunol Methods. 1995; 180(1):1-13.
18. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods. 1983; 64(3):313-20.
19. Konjevic G, Jurisic V, Spuzic I. Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients. Breast cancer research and treatment. 2001; 66(3):255-63.
20. Konjevic G, Jurisic V, Spuzic I. Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity. J Immunol Methods. 1997; 200(1-2):199-201.
21. Karimi MA, Lee E, Bachmann MH, Salicioni AM, Behrens EM, Kambayashi T, et al. Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay. PLoS One. 2014; 9(2):e89357. doi: 10.1371/journal.pone.0089357 PMID: 24586714; PubMed Central PMCID: PMC3929704.
22. Jang YY, Cho D, Kim SK, Shin DJ, Park MH, Lee JJ, et al. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells. Annals of clinical and laboratory science. 2012; 42(1):42-9.
23. Neri S, Mariani E, Meneghetti A, Cattini L, Facchini A. Calcein-Acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clinical and diagnostic laboratory immunology. 2001; 8(6):1131-5. doi: 10.1128/CDLI.8.6.1131-1135.2001 PMID: 11687452; PubMed Central PMCID: PMC96238.
24. Somanchi SS, Senyukov VV, Denman CJ, Lee DA. Expansion, purification, and functional assessment of human peripheral blood NK cells. J Vis Exp, 2011;(48: ), e2540, 103791/2540. Epub 2011/02/23. 2540 [pii] doi: 10.3791/2540
25. Denman CJ, Senyukov VV, Somanchi SS, Phatarpekar PV, Kopp LM, Johnson JL, et al. Membranebound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One. 2012; 7 (1):e30264. Epub 2012/01/27. doi: 10.1371/journal.pone.0030264; PubMed Central PMCID: PMC3261192.
26. Vanherberghen B, Olofsson PE, Forslund E, Sternberg-Simon M, Khorshidi MA, Pacouret S, et al. Classification of human natural killer cells based on migration behavior and cytotoxic response. Blood. 2013; 121(8):1326-34. doi: 10.1182/blood-2012-06-439851
27. Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, et al. Activation of NK cell cytotoxicity. Mol Immunol. 2005; 42(4):501-10. doi: 10.1016/j.molimm.2004.07.034
28. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol. 2002; 2(10):735-47. doi: 10.1038/nri911
29. Chan LL, Wilkinson AR, Paradis BD, Lai N. Rapid image-based cytometry for comparison of fluorescent viability staining methods. Journal of fluorescence. 2012; 22(5):1301-11. doi: 10.1007/s10895-012-1072-y
30. Chan LL, Zhong X, Qiu J, Li PY, Lin B. Cellometer vision as an alternative to flow cytometry for cell cycle analysis, mitochondrial potential, and immunophenotyping. Cytometry A. 2011; 79(7):507-17. doi: 10.1002/cyto.a.21071
31. Nagao F, Yabe T, Xu M, Yokoyama K, Saito K, Okumura K. Application of non-radioactive europium (Eu3+) release assay to a measurement of human natural killer activity of healthy and patient populations. Immunol Invest. 1996; 25(5-6):507-18.
32. Wierda WG, Mehr DS, Kim YB. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay. J Immunol Methods. 1989; 122(1):15-24.
33. Kolber MA, Quinones RR, Gress RE, Henkart PA. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF). J Immunol Methods. 1988; 108(1-2):255-64.
34. Erskine CL, Henle AM, Knutson KL. Determining optimal cytotoxic activity of human Her2neu specific CD8 T cells by comparing the Cr51 release assay to the xCELLigence system. J Vis Exp. 2012;(66: ): e3683. doi: 10.3791/3683; PubMed Central PMCID: PMC3476764.
35. Lundqvist A, Su S, Rao S, Childs R. Cutting edge: bortezomib-Treated tumors sensitized to NK cell apoptosis paradoxically acquire resistance to antigen-specific T cells. J Immunol. 2010; 184(3):1139-42. doi: 10.4049/jimmunol.0902856
36. Lundqvist A, Abrams SI, Schrump DS, Alvarez G, Suffredini D, Berg M, et al. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Res. 2006; 66(14):7317-25. doi: 10.1158/0008-5472.CAN-06-0680
37. Hallett WH, Ames E, Motarjemi M, Barao I, Shanker A, Tamang DL, et al. Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition. J Immunol. 2008; 180(1):163-70.
38. Wennerberg E, Sarhan D, Carlsten M, Kaminskyy VO, D'Arcy P, Zhivotovsky B, et al. Doxorubicin sensitizes human tumor cells to NK cell-And T-cell-mediated killing by augmented TRAIL receptor signaling. Int J Cancer. 2013; 133(7):1643-52. doi: 10.1002/ijc.28163
39. Devevre E, Romero P, Mahnke YD. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry. J Immunol Methods. 2006; 311 (1-2):31-46.
40. Zaritskaya L, Shafer-Weaver KA, Gregory MK, Strobl SL, Baseler M, Malyguine A. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials. J Immunother. 2009; 32(2):186-94.
41. Jedema I, van der Werff NM, Barge RM, Willemze R, Falkenburg JH. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood. 2004; 103(7):2677-82. doi: 10.1182/blood-2003-06-2070
42. Park KH, Park H, Kim M, Kim Y, Han K, Oh EJ. Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-Time cell electronic sensing system. BioMed research international. 2013; 2013:210726. doi: 10.1155/2013/210726 PMID: 24236291; PubMed Central PMCID: PMC3819884.
43. Guldevall K, Vanherberghen B, Frisk T, Hurtig J, Christakou AE, Manneberg O, et al. Imaging immune surveillance of individual natural killer cells confined in microwell arrays. PLoS One. 2010; 5(11): e15453. doi: 10.1371/journal.pone.0015453; PubMed Central PMCID: PMC2980494.
44. Bhat R, Watzl C. Serial killing of tumor cells by human natural killer cells-enhancement by therapeutic antibodies. PLoS One. 2007; 2(3):e326. doi: 10.1371/journal.pone.0000326; PubMed Central PMCID: PMC1828617.
45. Choi PJ, Mitchison TJ. Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells. Proc Natl Acad Sci U S A. 2013; 110(16):6488-93. doi: 10.1073/pnas.1221312110; PubMed Central PMCID: PMC3631668.
46. Forslund E, Guldevall K, Olofsson PE, Frisk T, Christakou AE, Wiklund M, et al. Novel Microchip-Based Tools Facilitating Live Cell Imaging and Assessment of Functional Heterogeneity within NK Cell Populations. Front Immunol. 2012; 3:300. doi: 10.3389/fimmu.2012.00300; PubMed Central PMCID: PMC3464457.